Moneycontrol PRO

business

Sun Pharma down 6% on 14-page USFDA observations letter to Halol

Healthcare major Sun Pharmaceutical Industries shares plunged more than 6 percent intraday Wednesday on US Food and Drug Administration (USFDA) concerns. According to IIFL, the US health regulator has issued 14-page 483 observations letter after inspection of Sun Pharma's Halol unit in Gujarat.

first published: Dec 7, 2016 10:56 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347